Every commercial decision is a bet. The question is whether you are betting on something you can stand behind. The Healthcare Map gives you current  Rx and Mx trends, HCP prescribing data and behavior shifts, competitive drug utilization dynamics, and more in real time. Your team acts on intelligence they can trust, before the shift shows up in anyone else’s analysis. 

Real-world evidence is only as defensible as the data underneath it. The Healthcare Map gives you full longitudinal history, minimal attrition bias, and reproducible cohort construction so your outputs hold up in publications and payer dossiers. Not because you built the methodology carefully. Because the foundation was right from the start.

Published literature tells you what was studied. The Healthcare Map tells you what’s happening in the real world. Treatment patterns from diagnosis through gaps, switches, and discontinuation: the context that turns a scientific conversation into a relevant one. Your MSL team walks in with the published evidence and the real-world picture to back it up. That’s a harder conversation for anyone to match.

The difference between a trial that enrolls on time and one that doesn’t often comes down to what you knew before you committed. The Healthcare Map gives you the complete picture: size patient populations, run feasibility assessments, and model control arms using the most complete open and closed claims universe available. No extrapolation. No guesswork. Just the right foundation before the wrong decision gets made.

Healthcare decisions move markets. The question is whether you see it coming. The Healthcare Map gives financial services teams the same intelligence that powers decisions inside the world’s leading healthcare organizations, from treatment adoption curves, prescribing shifts, and utilization trends, before they show up in earnings calls. The signal was always in the data. Now you can find it first.